Intel Claims It’s On Track To Catch Up By 2026 Despite A Lackluster Outlook
Intel Corporation (NASDAQ: INTC) fell short of revenue estimates, but topped earnings per share estimates with its first quarter financials.
Apple Continues Being Mysterious About AI While Services Reach A New Revenue Record And The iPhone Continues Its Fall From Glory
On Thursday, Apple Inc (NASDAQ: AAPL) issued its fiscal second quarter results and although they were slightly higher than Wall Street expected, Apple posted a revenue drop, including falling iPhone sales. But Apple’s biggest news were that the board authorized its largest ever share buyback.
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
After topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co Inc (NYSE: MRK) just reported encouraging data from its Phase III gastric cancer treatment trial after ending 2023 with good news from its combined treatment with Moderna Inc (NASDAQ:
GM and Ford’s Earnings Beat Could Be A Double-Edged Sword For Their EV Transformation
Last week, Ford Motor (NYSE: F) and General Motors (NYSE: GM) topped Wall Street estimates with their first quarter results. But, they did it on the back of their internal-combustion engine vehicles, more precisely, trucks, that managed to offset EV losses.
Starbucks’s Financials Are In Needs Of A Pick Me Up Coffee
On Tuesday, Starbucks Corporation (NASDAQ: SBUX) delivered a depressing quarterly report and forecast.
Amazon’s Smashing Q1 Financials Show The Power Of A Good And Well Executed Strategy
Like Meta Platforms (NASDAQ: META), Snap Inc (NYSE: SNAP) and Google parent Alphabet (NASDAQ: GOOG)(NASDAQ: GOOGL<
Snap Finally Advances On The Ad Front
Last Thursday, Snap Inc (NYSE: SNAP) reported its first quarter financials, showing that the improvements it made to its advertising system showed results faster than anticipated.
Stellantis And Volkswagen Are Off To A Slow Start
After the EV king, Tesla Inc (NASDAQ: TSLA) reported its biggest revenue drop since 2012, along with a sinking profit, Stellantis N.V.
mRNA Is Promising A Breakthrough In Fighting Cancer
When it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during the COVID-19 era as it allowed pharmaceutical companies like Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ:
Microsoft Tops Estimates Across Its Business But Signals Near-Term Capacity Challenges
On Thursday, Microsoft Corporation (NASDAQ: MSFT) issued its third quarter earnings report.